Inventor
LIN SONGNIAN
US30 patents
⚠️ This page may combine multiple inventors who share the name “LIN SONGNIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
20 patentsUS10183981B2Jan 22, 2019
Insulin receptor partial agonists
MERCK SHARP & DOHME5 citations83
US9427475B2Aug 30, 2016
Glucose-responsive insulin conjugates
MERCK SHARP & DOHME5 citations83
US7759493B2Jul 20, 2010
Antidiabetic bicyclic compounds
MERCK SHARP & DOHME9 citations79
US10017556B2Jul 10, 2018
Insulin receptor partial agonists
MERCK SHARP & DOHME3 citations72
US11041009B2Jun 22, 2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
MERCK SHARP & DOHME2 citations71
US9884125B2Feb 6, 2018
Glucose-responsive insulin conjugates
MERCK SHARP & DOHME3 citations70
US8039484B2Oct 18, 2011
Antidiabetic bicyclic compounds
MERCK SHARP & DOHME2 citations62
US10689430B2Jun 23, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME1 citations61
US10953076B2Mar 23, 2021
Insulin receptor partial agonists and GLP-1 analogues
MERCK SHARP & DOHME0 citations60
US11530250B2Dec 20, 2022
Tyrosine-specific functionalized insulin and insulin analogs
MERCK SHARP & DOHME0 citations57
US11058775B2Jul 13, 2021
Insulin dimer-incretin conjugates
MERCK SHARP & DOHME0 citations52
US11077092B2Aug 3, 2021
Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor
MERCK SHARP & DOHME0 citations51
US10800827B2Oct 13, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME0 citations51
US9889205B2Feb 13, 2018
Glucose-responsive insulin conjugates
MERCK SHARP & DOHME0 citations51
US9649294B2May 16, 2017
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME0 citations51
US9527838B2Dec 27, 2016
2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
MERCK SHARP & DOHME1 citations51
US11820805B2Nov 21, 2023
Conjugate based systems for controlled insulin delivery
MERCK SHARP & DOHME0 citations49
US10065945B2Sep 4, 2018
Isoquinoline derivatives as MGAT2 inhibitors
MERCK SHARP & DOHME0 citations39
US9359339B2Jun 7, 2016
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME0 citations39
US9453038B2Sep 27, 2016
Glucokinase activator compounds, compositions containing such compounds, and methods of treatment
MERCK SHARP & DOHME0 citations38
LIN SONGNIAN
4 patentsUS8318667B2Nov 27, 2012
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
LIN SONGNIAN2 citations58
US8324384B2Dec 4, 2012
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
LIN SONGNIAN0 citations37
US8445538B2May 21, 2013
Glucagon receptor antagonist compounds
LIN SONGNIAN0 citations36
US8436015B2May 7, 2013
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
LIN SONGNIAN0 citations36
MERCK SHARP & DOHME LLC
3 patentsUS11413352B2Aug 16, 2022
Conjugate based systems for controlled insulin delivery
MERCK SHARP & DOHME LLC2 citations65
US11827684B2Nov 28, 2023
Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer
MERCK SHARP & DOHME LLC0 citations59
US12427187B2Sep 30, 2025
Glucose-responsive insulin conjugates
MERCK SHARP & DOHME LLC0 citations50